The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice

Pharmacology Biochemistry and Behavior

Volumn 101, Issue 2, 2012, Pages 303-306

  Fujita, Yuko ^a   Kunitachi, Shinsui ^a   Iyo, Masaomi ^a   Hashimoto, Kenji ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Dependence; Dopamine; Methamphetamine; Minocycline; Nucleus accumbens; Reward

Indexed keywords

DOPAMINE; METHAMPHETAMINE; MINOCYCLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IN VIVO STUDY; MICRODIALYSIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

ANIMALS; ANTI-BACTERIAL AGENTS; CONDITIONING (PSYCHOLOGY); DOPAMINE; METHAMPHETAMINE; MICE; MICE, INBRED C57BL; MINOCYCLINE; REWARD;

MUS;

EID: 84857638421     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2012.01.005     Document Type: Article

References (29)

1. N. Ahuja, and B.T. Carroll Possible anti-catatonic effects of minocycline in patients with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 31 2007 968 969 (Pubitemid 46671479)
2. C. Chaves, C.R. de Marque, L. Wichert-Ana, J.P. Maia-de-Oliveira, E.N. Itikawa, and J.A. Crippa Functional neuroimaging of minocycline's effect in a patient with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 34 2010 550 552
3. H. Chen, J. Wu, J. Zhang, and K. Hashimoto Recent topics on pharmacotherapy for amphetamine-type stimulants abuse and dependence Curr Drug Abuse Rev 3 2010 222 238
4. M. Domercq, and C. Matute Neuroprotection by tetracyclines Trends Pharmacol Sci 25 2004 609 612 (Pubitemid 39458165)
5. K.B.L. Frankin, and G. Paxinos The mouse brain in stereotaxic coordinates 1997 Academic Press San Diego, CA
6. Y. Fujita, T. Ishima, S. Kunitachi, H. Hagiwara, L. Zhang, and M. Iyo Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline Prog Neuropsychopharmacol Biol Psychiatry 32 2008 336 339 (Pubitemid 351178944)
7. R. Gonzales, L. Mooney, and R.A. Rawson The methamphetamine problem in the United States Annu Rev Public Health 31 2010 385 398
8. K. Hashimoto Chapter 1. New research on methamphetamine abuse G.H. Toolaney, New research on methamphetamine abuse 2007 Nova Science Publishers, Inc. New York 1 51
9. K. Hashimoto Minocycline as a therapeutic drug for methamphetamine use disorders Nihon Shinkei Seishin Yakurigaku Zasshi 28 2008 19 22 (Pubitemid 351413132)
10. K. Hashimoto Microglial activation in schizophrenia and minocycline treatment Prog Neuropsychopharmacol Biol Psychiatry 32 2008 1758 1759
11. K. Hashimoto Abnormality of cerebral perfusion in the posterior cingulate gyrus of a refractory patient with schizophrenia and minocycline treatment Prog Neuropsychopharmacol Biol Psychiatry 34 2010 1132
12. K. Hashimoto, and T. Ishima A novel target of action of minocycline in NGF-induced neurite outgrowth in PC12 cells: translation initiation factor eIF4AI PLoS One 5 2010 e15430
13. K. Hashimoto, H. Tsukada, S. Nishiyama, D. Fukumoto, T. Kakiuchi, and M. Iyo Protective effects of minocycline on the reduction of dopamine transporters in the striatum after administration of methamphetamine: a PET study in conscious monkeys Biol Psychiatry 61 2007 577 581 (Pubitemid 46328849)
14. S. Ikemoto Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex Brain Res Rev 56 2007 27 78 (Pubitemid 350110353)
15. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br J Clin Pharmacol 69 2010 578 592
16. Y. Levkovitz, U. Levi, Y. Braw, and H. Cohen Minocycline, a second-generation tetracycline, as a neuroprotective agent in an animal model of schizophrenia Brain Res 1154 2007 154 162 (Pubitemid 46856336)
17. Y. Levkovitz, S. Mendlovich, S. Riwkes, Y. Braw, H. Levkovitch-Verbin, and G. Gal A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia J Clin Psychiatry 71 2010 138 149
18. C. Lüscher, and R.C. Malenka Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling Neuron 69 2011 650 663
19. T. Miyaoka Clinical potential of minocycline for schizophrenia CNS Neurol Disord Drug Targets 7 2008 376 381
20. T. Miyaoka, R. Yasukawa, H. Yasuda, M. Hayashida, T. Inagaki, and J. Horiguchi Minocycline as adjunctive therapy for schizophrenia: an open-label study Clin Neuropharmacol 31 2008 287 292
21. P. Munzar, H. Li, K.L. Nicholson, J.L. Wiley, and R.L. Balster Enhancement of the discriminative stimulus effects of phencyclidine by the tetracycline antibiotics doxycycline and minocycline in rats Psychopharmacology (Berl) 160 2002 331 336 (Pubitemid 34230685)
22. J. Patel, K.A. Mooslehner, P.M. Chan, P.C. Emson, and J.A. Stamford Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice J Neurochem 85 2003 898 910 (Pubitemid 36578622)
23. M. Sofluoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
24. M. Sofuoglu, and R.A. Sewell Norepinephrine and stimulant addiction Addict Biol 14 2009 119 129
25. M. Sofuoglu, M. Mooney, T. Kosten, A. Waters, and K. Hashimoto Minocycline attenuates subjective-rewarding effects of dextroamphetamine in humans Psychopharmacology 213 2011 61 68
26. Y. Tanibuchi, M. Shimagami, G. Fukami, Y. Sekine, M. Iyo, and K. Hashimoto A case of methamphetamine use disorder treated with the antibiotic minocycline Gen Hosp Psychiatry 32 2010 559e1-e3
27. L. Zhang, K. Kitaichi, Y. Fujimoto, H. Nakayama, E. Shimizu, and M. Iyo Protective effects of minocycline on behavioral changes and neurotoxicity in mice after administration of methamphetamine Prog Neuropsychopharmacol Biol Psychiatry 30 2006 1381 1393 (Pubitemid 44634942)
28. L. Zhang, Y. Shirayama, E. Shimizu, M. Iyo, and K. Hashimoto Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain Eur J Pharmacol 544 2006 1 9 (Pubitemid 44148565)
29. L. Zhang, Y. Shirayama, M. Iyo, and K. Hashimoto Minocycline attenuates hyperlocomotion and prepulse inhibition deficits in mice after administration of the NMDA receptor antagonist dizocilpine Neuropsychopharmacology 32 2007 2004 2010 (Pubitemid 47258509)